Proto-Oncogene Protein c-ets-1
"Proto-Oncogene Protein c-ets-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ets proto-oncogene protein expressed primarily in adult LYMPHOID TISSUE; BRAIN; and VASCULAR ENDOTHELIAL CELLS.
| Descriptor ID |
D050784
|
| MeSH Number(s) |
D12.776.260.665.100 D12.776.624.664.700.175.100 D12.776.930.720.100
|
| Concept/Terms |
Proto-Oncogene Protein c-ets-1- Proto-Oncogene Protein c-ets-1
- Proto Oncogene Protein c ets 1
- c-ets-1, Proto-Oncogene Protein
- c-ets-1 Protein
- c ets 1 Protein
- Proto-Oncogene Protein ets-1
- Proto Oncogene Protein ets 1
- ets-1, Proto-Oncogene Protein
- Proto-Oncogene Proteins c-ets-1
- Proto Oncogene Proteins c ets 1
- c-ets-1, Proto-Oncogene Proteins
- Ets-1 Transcription Factor
- Ets 1 Transcription Factor
- Transcription Factor, Ets-1
- c-ets1 Transcription Factor
- Transcription Factor, c-ets1
- c ets1 Transcription Factor
|
Below are MeSH descriptors whose meaning is more general than "Proto-Oncogene Protein c-ets-1".
Below are MeSH descriptors whose meaning is more specific than "Proto-Oncogene Protein c-ets-1".
This graph shows the total number of publications written about "Proto-Oncogene Protein c-ets-1" by people in this website by year, and whether "Proto-Oncogene Protein c-ets-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Proto-Oncogene Protein c-ets-1" by people in Profiles.
-
Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemia. Blood Cancer Discov. 2020 09; 1(2):178-197.
-
Batf Pioneers the Reorganization of Chromatin in Developing Effector T Cells via Ets1-Dependent Recruitment of Ctcf. Cell Rep. 2019 10 29; 29(5):1203-1220.e7.
-
Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements. Eur J Immunol. 2017 05; 47(5):800-805.
-
The ETS1 transcription factor is required for the development and cytokine-induced expansion of ILC2. J Exp Med. 2016 05 02; 213(5):687-96.
-
PAX3 and ETS1 synergistically activate MET expression in melanoma cells. Oncogene. 2015 Sep 17; 34(38):4964-74.
-
The molecular choreography of IRF4 and IRF8 with immune system partners. Cold Spring Harb Symp Quant Biol. 2013; 78:101-4.
-
Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013 May 23; 38(5):918-29.
-
The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2. PLoS One. 2012; 7(5):e37151.
-
Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity. 2012 Jun 29; 36(6):921-32.
-
Chromatin occupancy analysis reveals genome-wide GATA factor switching during hematopoiesis. Blood. 2012 Apr 19; 119(16):3724-33.